UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Annals of oncology, 2013-12, Vol.24 (12), p.3128-3135

2013

Volltextzugriff (PDF)

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor―Transduced Human T cells in Solid Tumors

Clinical cancer research, 2014-08, Vol.20 (16), p.4262-4273

2014

Volltextzugriff (PDF)

Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor

Clinical cancer research, 2011-07, Vol.17 (14), p.4719-4730

2011

Volltextzugriff (PDF)

Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma

Cancer research (Chicago, Ill.), 2014-08, Vol.74 (16), p.4388-4397

2014

Volltextzugriff (PDF)

Iron overload signature in chrysotile-induced malignant mesothelioma

The Journal of pathology, 2012-11, Vol.228 (3), p.366-377

2012

Volltextzugriff (PDF)

Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients

Clinical cancer research, 2012-05, Vol.18 (9), p.2478-2489

2012

Volltextzugriff (PDF)

Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2

Cancer research (Chicago, Ill.), 2007-08, Vol.67 (15), p.7458-7466

2007

Volltextzugriff (PDF)

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

Human pathology, 2010, Vol.41 (1), p.20-25

2010

Volltextzugriff (PDF)

PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma

The American journal of surgical pathology, 2010-05, Vol.34 (5), p.627-635

2010

Volltextzugriff (PDF)

New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment

Clinical cancer research, 2012-09, Vol.18 (17), p.4485-4490

2012

Volltextzugriff (PDF)

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

British journal of cancer, 2014-01, Vol.110 (2), p.510-519

2014

Volltextzugriff (PDF)

The Diagnostic Utility of p16 FISH and GLUT-1 Immunohistochemical Analysis in Mesothelial Proliferations

American journal of clinical pathology, 2011-04, Vol.135 (4), p.619-627

2011

Volltextzugriff (PDF)

Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or Pleura

Clinical cancer research, 2006-10, Vol.12 (19), p.5777-5785

2006

Volltextzugriff (PDF)

Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study

Journal of clinical oncology, 2007-06, Vol.25 (17), p.2406-2413

2007

Volltextzugriff (PDF)

The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma

British journal of cancer, 2013-04, Vol.108 (6), p.1340-1347

2013

Volltextzugriff (PDF)

Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Clinical cancer research, 2012-01, Vol.18 (1), p.77-90

2012

Volltextzugriff (PDF)

Global gene expression profiling of pleural mesotheliomas : Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.2970-2979

2006

Volltextzugriff (PDF)

Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)

Lung cancer (Amsterdam, Netherlands), 2012-07, Vol.77 (1), p.192-198

2012

Volltextzugriff (PDF)

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

Journal of clinical oncology, 2010-03, Vol.28 (9), p.1534-1539

2010

Volltextzugriff (PDF)

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Clinical cancer research, 2011-04, Vol.17 (8), p.2581-2590

2011

Volltextzugriff (PDF)

T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo

Clinical cancer research, 2014-02, Vol.20 (4), p.962-971

2014

Volltextzugriff (PDF)

Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy?

International journal of cancer, 2013-11, Vol.133 (9), p.2077-2088

2013

Volltextzugriff (PDF)

Curcumin: A Double Hit on Malignant Mesothelioma

Cancer prevention research (Philadelphia, Pa.), 2014-03, Vol.7 (3), p.330-340

2014

Volltextzugriff (PDF)

Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells

Food and chemical toxicology, 2013-02, Vol.52, p.61-68

2013

Volltextzugriff (PDF)

Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation

The American journal of surgical pathology, 2011-06, Vol.35 (6), p.878-882

2011

Volltextzugriff (PDF)

1 – 25 von 687

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(639)
Mit Volltextzugriff
(611)

Publikationsform

Artikel
(687)

Sprache

Englisch
(687)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(687)
Science & Technology
(648)
Life Sciences & Biomedicine
(647)
Humans
(643)
Mesothelioma - Metabolism
(395)
Oncology
(345)
Pneumology
(305)
Mesothelioma - Pathology
(303)
Male
(295)
Female
(289)
Mesothelioma
(286)
Tumors Of The Respiratory System And Mediastinum
(279)
Tumors
(265)
Middle Aged
(216)
Aged
(206)
Immunohistochemistry
(194)
Pleural Neoplasms - Metabolism
(188)
Pathology
(179)
Adult
(152)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor―Transduced Human T cells in Solid Tumors

Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor

Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma

Iron overload signature in chrysotile-induced malignant mesothelioma

Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients

Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma

New Strategies in Pleural Mesothelioma: BAP1 and NF2 as Novel Targets for Therapeutic Development and Risk Assessment

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

The Diagnostic Utility of p16 FISH and GLUT-1 Immunohistochemical Analysis in Mesothelial Proliferations

Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or Pleura

Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study

The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma

Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy

Global gene expression profiling of pleural mesotheliomas : Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction

Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo

Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy?

Curcumin: A Double Hit on Malignant Mesothelioma

Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells

Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation

Aktive Filter

Suchergebnisse filtern